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Summary
Marine microbial populations collected from the
Hawaiian Islands were screened for antimicrobial
activity. A blue metabolite was identified from mixed
cell cultures, but production was not evident in pure
cultures. Experiments designed to probe the synergis-
tic role of the microorganisms are presented. Full
characterization of the blue natural product, pyocya-
nin, is provided including corrections made to 1H
and 13C-NMR assignments of the molecule misre-
ported in the chemical literature and yeast transcrip-
tome analysis. The transcriptional effectswere consis-
tent with the compound’s purported role as an inducer
of oxidative stress and damage and illustrates the
overall potential of themethod to reveal the primary bi-
ological/cellular effects of a natural product. The ex-
periments outlined here might serve as a general par-
adigm for identification of natural products arising
from microbial communities and investigation of their
respective interactions.
Introduction
Natural products and their structural analogs account
for approximately 60% of new small-molecule drugs to
enter the market over the past 20 years [1]. Notable
triumphs include Taxol, produced from the Pacific yew
tree and one of the most successful anticancer agents
of the past decade [2], as well as vancomycin, often
referred to as the drug of last resort, the last line of
defense for treatment of drug-resistant Staphylococcus
aureus infections [3]. Both drugs have generated $1
billion in annual sales [3, 4].
Traditional methods to mining natural products entail
organism collection, extraction, bioassay-guided purifi-
cation, and structure determination. Among possible
sources, the marine environment has provided an abun-
dant supply of natural products with a diverse array of
structures and bioactivities, including antimicrobial,
immunosuppressive, and anticancer agents [5, 6].
Indeed, ziconotide, the synthetic form of the cone snail
peptide w-cenotoxin M-VII-A, a neuron-specific N-type
calcium channel blocker, has recently entered the mar-
ket for treatment of severe chronic pain [7].
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his 50th birthday.Sponges and ‘‘culturable’’ microorganisms are com-
mon resources for the discovery of marine-derived
therapeutics. Microorganisms can offer the added
advantage of providing a continuous supply of the natu-
ral product, albeit it is frequently debated as to whether
the sponge itself or microorganisms living within the
sponge environment are responsible for natural product
production [8–10]. The general strategy for identifying
microorganisms from marine habitats typically involves
screening microbial isolates for bioactivity. Here, we in-
vestigate marine microbial communities for antibiotic/
antifungal activity, bearing the hypothesis in mind that
natural product production, i.e., the regulation and
expression of their respective biosynthetic pathways,
could be coupled with microbial interactions. Indeed,
bacteria isolated from marine snow particle-microbial
communities have been shown to display potent
antagonistic effects, offering some support for this
mechanism [11, 12].
Results and Discussion
Isolation of Pup14
Samples were collected from the north shore of Oahu,
Hawaii. Ocean floor sediments (up to a depth of 40 ft)
were obtained as well as culture swabs of submerged
rocks. The microorganism specimens were plated on
bacterial or fungal plates employing standard literature
protocols [13]. Microbial communities were inoculated
into liquid media and cultured in shake flasks. Among
the microorganism samples examined, Pup14 (Pupukea
sample 14, bacterial plate) gave an unusual green phe-
notype following w72 hr of culturing; while the cells
remained white, the medium turned green. Extraction
of the medium resulted in an aqua blue color. Crude
extracts of the Pup14 sample were found to be moder-
ately active against E. coli and yeast (IC50 = 25 mg/ml).
Interestingly, the Pup14 sample showed that cells prop-
agated from single colonies and grown in culture could
not generate the green phenotype, suggesting microbial
crosstalk—that natural product production was in some
way coupled with microbial interactions.
Establishing Microbial Synergism of Pup14A
and Pup14B
Therefore, to investigate the possibility that microbial
interplay was necessary for stimulating natural product
production, we initially took a split-pool approach. Sixty
single colonies were picked and maintained individually
on marine agar plates. Colonies were first pooled ten at
a time, assayed for the green phenotype, and upon con-
firmation, the colonies were further split and pooled until
it was determined that two microorganisms, designated
here as Pup14A and Pup14B, were necessary for
production of the blue metabolite (Figure 1).
At this point, two basic scenarios were envisioned.
Either one strain is the inducer and one the producer
or one strain generates a metabolic precursor that
is subsequently converted by the other to give the
final product. To decipher between these possible
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Pup14B Cultures and Extracts Are Shown
(A) Pup14A and Pup14B following 24 hr of
culturing at 30C, 250 rpm.
(B) Pup14A and Pup14B following 72 hr of
culturing at 30C, 250 rpm.
(C) Pup14 crude extract generated by
extraction of the medium (72 hr) with
methylene chloride.mechanisms, we performed a series of experiments. We
first examined the natural product for toxicity against
these strains. Overnight cultures of Pup14A and
Pup14B were generated, diluted to an OD600 0.1, and ali-
quoted into a 96-well plate. To each culture was added
ethanol vehicle (serving as a control) or the purified
blue metabolite to give final concentrations of 10 mg/
ml, 100 mg/ml, and 1 mg/ml. The cultures were incubated
with shaking for an additional 12 hr, and cell density was
measured with a Biotek microplate reader. Cellular cy-
toxicity was, however, not observed with either
Pup14A or Pup14B.
We, therefore, varied the ratio of Pup14A and Pup14B
inoculated, which revealed that equal volumes of each
microorganism were most effective at inducing natural
product production. Skewing the ratio in favor of
Pup14A over Pup14B resulted in a loss of induction,
whereas inoculating with negligible amounts of
Pup14A versus that of Pup14B still gave the green phe-
notype (and similar levels of production), but with de-
layed onset. This suggested a mechanism whereby
Pup14A is the inducer and Pup14B is the producer.
Moreover, as the natural product was produced in
similar quantities in either case (whether equal or
skewed cell ratios were utilized), the mechanism of acti-
vation does not likely involve the generation of an inter-
mediate by one strain followed by metabolite transfer
and biosynthesis by the other strain to give the final
product.
A small-molecule exchange assay was performed
where the cells of one were introduced into the media
of the other and vice versa. The experiment was carried
out at two different time points, 24 and 72 hr, respec-
tively. Two sets of Pup14A and Pup14B cultures were
thus generated and harvested by centrifugation at the
appropriate time point, and the media were sterile-
filtered. The cells of Pup14A were introduced into the
media of Pup14B and vice versa (Pup14B cells intro-
duced into the media of Pup14A). Induction, however,
was not observed in either case. Therefore, small-
molecule production by Pup14A alone was not sufficient
for activation. Induction of the green phenotype might
require cell-cell contact, or more complex mechanisms
could be at work, such as metabolite exchange between
microorganisms [14–16].
To address this issue and decipher between these
two mechanisms, a Boyden chamber (consisting of
two wells separated by a membrane) or transwell assay
was carried out (Figure 2A). The producing strain,
Pup14B, was inoculated into the bottom chamber, and
Pup14A, the activating strain, into the top chamber.
The cells were incubated at 30C in an incubator,
without shaking, for 2 days, extracted with methylene
chloride, and compared visually to a set of controlswhere: (1) Pup14B was inoculated into the bottom
chamber of one well (the top chamber containing noth-
ing), or (2) Pup14A and Pup14B were mixed together
(no membrane separation). Activation of the blue pheno-
type was observed when Pup14A and Pup14B were
mixed together or when separated by a membrane (Fig-
ures 2C and 2D). In fact, activation was slightly
enhanced when there was no cell contact (Figure 2D).
As expected, no activation was observed when
Pup14B was cultured alone (Figure 2B). Additionally,
to ensure that the microorganisms could not penetrate
the membrane, both Pup14A and Pup14B were each
added to the top chamber of separate wells with the
bottom chamber containing medium alone and incu-
bated for 2 days. In neither case was translocation to
the bottom chamber observed. The medium in the
bottom chamber remained clear. The results from these
experiments favor a mechanism in which metabolite
exchange between the two microorganisms is neces-
sary to induce the green phenotype.
To determine whether the interaction was specific
between Pup14A and Pup14B or whether any microor-
ganism could activate Pup14B, the microorganism
was cultured with an assortment of other microorgan-
isms. Pup14B was cultured for a week with microorgan-
isms Hon6, Pup16, Surf1, and KM1. Pup14A was also
cultured with these same microorganisms serving as
a control set. While none of the Pup14A mixed cultures
gave the green phenotype, Pup14B cultured with KM1
resulted in activation of the strain, albeit to a lesser ex-
tent than when cultured with Pup14A. Microorganisms
were sent to the Centrallbureau voor Schimmelcultures
in the Netherlands (CBS) for bacterial classification.
The results are depicted in Table 1. Pup14A was identi-
fied as Enterobacter sp. and Pup14B as Pseudomonas
aeruginosa, a quorum-sensing bacterium [17–19]. Quo-
rum sensing is a phenomenon used by diverse bacteria
Figure 2. Results of Boyden Chamber Assay
(A) Pictorial diagram of the transwell chamber.
(B–D) Organic extracts obtained from Boyden chamber assay are
shown: (B) Pup14B alone (bottom chamber), (C) Pup14A and
Pup14B mixed together in the same well, and (D) Pup14A (top
chamber) and Pup14B (bottom chamber).
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to express specific genes in a coordinated fashion, lead-
ing to a rapid and full-blown virulence cascade [15, 16].
A complex network of regulatory factors govern produc-
tion of secondary metabolites in Pseudomonas aerugi-
nosa that involve two quorum-sensing systems, las
and rhl [20–24]. At least three signaling molecules have
been identified that act as intercellular communication
signals. The acyl homoserine lactone signals, N-(2-
oxododecanoyl)homoserine lactone and N-butyryl
homoserine lactone, are each autoinducers, together
controlling 6%–11% of the Pseudomonas genome [20,
25–27]. The third intercellular signal is a quinolone com-
pound, 2-heptyl-3-hydroxy-4-quinolone, that serves
as a regulatory link between the las and rhl quorum-
sensing systems and controls the synthesis of multiple
virulence factors [20, 21]. In many strains of Pseudomo-
nas aeruginosa, a basal level of autoinducer is produced
at low culture densities, and as the population grows,
autoinducer concentrations increase. On reaching
a threshold concentration, the autoinducers activate
the virulence cascade, including that of secondary
metabolite production [28, 23]. Pup14B on the other
hand, the Pseudomonas aeruginosa strain we have iso-
lated, did not induce the blue phenotype in culture
without activation by another strain (Pup14A or KM1),
reflecting some likely evolutionary differences with this
strain. Intriguingly, KM1 like Pup14A is of the genus
Enterobacter, accounting for its ability to activate
production of the compound. Both Pseudomonas sp.
and Enterobacter sp. have been identified in microbial
biofilms among a variety of virulent pathogens, some
of which have been shown to be regulated by acylhomo-
serine lactone (AHL) quorum-sensing signals [29]. More-
over, cell-free supernatants of Pseudomonas aerugi-
nosa and Enterobacter agglomerans, were shown to
contain diketopiperizines (DKPs) capable of activating
an N-acylhomoserine lactone (AHL) biosensor [30].
Characterization of the Natural Product
Concurrent to these investigations, we obtained an
X-ray crystal structure of the blue natural product (Fig-
ure 3). Literature evaluation of Pseudomonas aerginosa
taken together with the X-ray crystal structure data
revealed that the identity of the compound was likely
pyocyanin; however, full characterization on the com-
pound was lacking. Therefore, in addition to providing
X-ray analysis, 1D 1H-NMR, and 13C-NMR data, we
performed 2D-NMR analyses of the compound includ-
ing H,H-COSY, HMBC, HSQC, and DEPT (Table 2). The
results revealed that some of the 1H-NMR and
13C-NMR signals in the spectra of the compound had
been misassigned in the 1989 report [31]. The proton
at carbon 3 was assigned to carbon 6, and vice versa.
Table 1. Species Identification of Microorganisms
Strain Species Identification
Pup14A Enterobacter
Pup14B Pseudomonas aeruginosa
Hon6 New species, 98% identical to Chromohalobacter
Pup16 Rhodotorula mucilaginosa
KM1 EnterobacterH,H-COSY showed coupling between protons 2, 3, and
4. Since protons at positions 3 and 6 have similar chem-
ical shifts, 8.12 and 7.99 ppm, respectively, the data
were misinterpreted. Moreover, 13C-NMR peaks corre-
sponding to carbons 5a and 9 and carbons 3 and 10a
were also reversed in their assignments. Carbon posi-
tions 3 and 9, located at 147.3 and 134.0 ppm, were
readily assigned on the basis of HSQC and DEPT exper-
iments, which revealed the presence of an attached
proton at these sites. This revealed an inversion of
peak assignments between these carbons and carbons
10a and 5a that have very similar chemical shifts, 146.7
and 134.4 ppm, respectively. Spectral data on the com-
pound are provided in Table 2 with corrections in place
and J-values listed.
Quorum Control of Pyocyanin
Intriguingly, two seven-gene phenazine biosynthetic loci
have been identified from Pseudomonas aeruginosa
PAO1 [32]. The two operons, designated as phzA1B1
C1D1E1F1G1 and phzA2B2C2D2E2F2G2, exhibit high
homology to phenazine biosynthetic operons from
P. fluorescens, P. aureofaciens, and P. chlororaphis
PCL1391 [33–35]. Additionally, Southern hybridization
analysis for the presence of the core phenazine biosyn-
thetic genes (phzA-G) in 30 bacterial strains (including
other P. aeruginosa strains) showed that the cluster
could be detected in 21 of these strains [32]. Two addi-
tional genes (phzM and phzS) located in the vicinity of
the phzA1B1C1D1E1F1G1 operon in PAO1 have been
shown to convert phenazine-1-carboxylic acid (PCA)
to pyocyanin [32]. Upstream of the phzA1B1C1D1E1
F1G1 operon is a well-conserved putative promoter
element required for quorum control, the las box, but
does not precede the phzA2B2C2D2E2F2G locus [27].
Instead, a gene, qscR, encodes a protein that negatively
regulates expression of a number of quorum-sensing
controlled genes including the phzA1B1C1D1E1F1G1
operon [36, 74].
We examined Pup14B for the presence of the gene
cluster and its quorum-sensing region by PCR analysis,
employing oligonucleotide probes flanking both the las
box and qscR regions of the two biosynthetic loci and
their respective upstream regions. PCR products were
Figure 3. X-Ray Crystal Structure of Pyocyanin
Gray, carbon; blue, nitrogen; white, hydrogen; red, oxygen.
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Position 1H d, mult; J (Hz) 13C d COSY HMBC HSQC DEPT
1 177.5 C
2 6.68, d; 8.7 115.5 H-3-H-2 C-3, C-4 H-2 CH
3 7.99, t; 8.4 147.3 H-2-H-3, H-4-H-3 H-3 CH
4 6.66, d; 8.4 95.3 H-3-H-4 C-2, C-3 H-4 CH
4a 136.4 5-Me C
5a 134.4 5-Me C
6 8.12, m 116.8 H-7-H-6 C-7,C-8 H-6 CH
7 8.12, m 138.1 H-6-H-7, H-8-H-7 C-8 H-7 CH
8 7.79, t; 7.0 128.0 H-7-H-8, H-9-H-8 C-6, C-7 H-8 CH
9 8.38, d; 8.4 134.0 H-8-H-9 H-9 CH
9a 138.5 C-7, C-8 C
10a 146.7 C-2, C-4 C
5-Me 4.29, s (3H) 36.7 H-5 CH3
All spectra were recorded in methanol-d4.
1H-NMR (300 MHz) spectra were recorded on a Varian Inova-300 spectrometer. 13C-NMR (125 MHz)
and 2D-NMR spectra were recorded on a Bruker ARX500 spectrometer.obtained in both cases and sequencing confirmed that
both of these regions are intact in the Pup14B strain
(BLAST alignments are provided as Supplemental Data
available with this article online). As with P. aeruginosa
PAO1, these results might suggest that the presence
of two differentially regulated phenazine biosynthetic
operons might give the bacterium the ability to more
easily modulate phenazine production and adapt to
environmental signals or growth phase [32].
Transcriptional Response to Pyocyanin Treatment
To further characterize pyocyanin, we investigated the
mode of action of the compound by profiling the effects
of the compound on the yeast transcriptome with Affy-
metrix oligonucleotide microarrays (Yeast S98 Array).
Data were obtained in duplicate at two concentrations
of agent, 25 and 250 mg/ml, at 6 hr of drug exposure
(Table 3). Differential mRNA gene expression (R2.5-
fold) was observed in 45 transcripts of the approxi-
mately 6200 genes that comprise the yeast genome.
The results are consistent with the proposed role of the
drug as an inducer of oxidative damage [37–40]. The
primary transcriptional response consisted of genes
involved in oxidative damage and stress, cell-wall main-
tenance and synthesis, and DNA damage. Secondary ef-
fects consisted of genes involved in protein synthesis,
drug resistance, transport, stress response, as well as
metabolic genes, cell-cycle-related effects, and several
unclassified transcripts.
The oxidative damage, cell-wall biosynthesis, and
DNA damage effects observed with pyocyanin treat-
ment are each fully consistent with the agent’s docu-
mented ability to redox cycle and oxidize glutathione
(L-g-glutamylcysteinylglycine) [41, 37]. A map correlat-
ing pyocyanin’s biochemical actions with its transcrip-
tional effects is depicted in Figure 4. Under aerobic
conditions, pyocyanin is reduced by NADH or NADPHby electron transfer, passing those electrons to O2 to
give superoxide radical (O2
2) and hydrogen peroxide
(H2O2). These oxidative species result in the oxidation
of glutathione (GSH, the primary oxygen detoxification
species and chemical modulator of redox potential
within the eukaryotic cytosol) [42–44] to its oxidized
state (GSSG). In this regard, glutathionine peroxidase
(GPX2) was upregulated by 4.7-fold. Glutathione perox-
idase neutralizes destructive peroxides by catalyzing
their reduction using glutathione as an electron source
[45]. Pyocyanin can also directly oxidize glutathione to
form pyocyanin radical and superoxide radical (O2
2),
placing further oxidative stress on the cell [41]. Reactive
oxygen species generated through pyocyanin exposure
can also oxidize residues of proteins and elicit oxidative-
stress-defense systems. Methionine sulfoxide reduc-
tase, for example, an oxidative damage-repair protein
that acts by catalyzing the reduction of methionine sulf-
oxide and other methyl sulfoxides to methyl sulfides,
was upregulated in its expression by 2.6-fold, consistent
with this notion [46]. Other oxidative stress proteins
upregulated with pyocyanin treatment included two
alcohol dehydrogenases, YPL088W and YNL134C, dif-
ferentially expressed by 3.1-fold and 3.7-fold, respec-
tively, at the high dose [48]. Although their exact
substrates are unknown, both have previously been
associated with oxygen stress response. Likewise, we
observed upregulation of glutathione S-transferase by
2.4-fold, a class of enzymes recruited for xenobiotic
detoxification [42, 47]. Somewhat paradoxically, three
genes normally upregulated by increases in oxygen con-
centration were found to be downregulated. These were
ctt1, a cytoplasmic catalase (22.6-fold) [49], and two
cytochrome c encoding transcripts, cyc7 (23.3-fold
and 24.3-fold at low and high doses, respectively) and
cyc1 (22.6-fold at high dose), which function in respira-
tion and electron transport [50]. Downregulation of
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1353Table 3. Transcriptional Effects of Pyocyanin on Yeast
Probe Set ORF/Gene Description 25 mg/ml 250 mg/ml
Protein-Synthesis Related
10210_at YLR136C/TIS11, tRNA-specific adenosine deaminase; transcription factor — 4.9
10226_at YLR107W/REX3, RNA exonuclease involved in RNA processing/degradation — 2.8
9413_f_at YMR230W/RPS10B, ribosomal protein — 3.2
5957_at YMR322c/SNO4, possible chaperon and cysteine protease — 2.8
9667_at RRN6P,RRN7P/rRNA transcription factors (RNAP I specific initiation factor) — 3.0
10976_at YJR047C/ANB1 translation initiation factor lF5A.2 — 24.7
Oxygen-Stress Related
5697_at YER042w/MXR1, responsible for the reduction of methionine sulfoxide — 2.6
7109_at YBR244W/GPX2, glutathione peroxidase — 4.7
7847_at YPL088W/similar to aryl alcohol dehydrogenase 2.4 3.1
8988_at YNL134C/putative alcohol dehydrogenase implicated in oxygen stress response — 3.7
4924_at YGR088W/ctt1 cytoplasmic catalase T 22.6 —
5751_at YEL039C/cyc7 iso-2-cytochrome c 23.3 24.3
10977_at YJR048W/cyc1 cytochrome c isoform 1 22.6 —
General Drug Resistance
10358_at YLL028W/TPO1, vacuolar polyamine/H+ antiporter — 4.1
4573_at YHL035C/VMR1, multidrug resistance protein, ABC protein — 2.5
4778_at YGR213C/RTA1, integral membrane protein involved in 7-aminocholesterol resistance — 5.9
8923_at YNLO65W/AQR1, membrane transporter — 4.7
9117_at YNL231C/PDR16, protein involved in lipid synthesis and multidrug resistance — 2.5
9328_at YMR279C/member of a family of multidrug resistance proteins 10.6 —
Transport Proteins
4936_at YGR055W/MUP1, high affinity methionine permease — 3.0
10852_at YJR150C/DAN1 protein only expressed during anaerobic growth — 22.9
10795_at YKL217W/JEN1 lactate and pyruvate permease 22.5 —
9065_at YNL194C/integral membrane protein localized to cell periphery 22.3 24.4
8528_at YOR11w/AUS1 ATP-binding cassette transporter — 22.8
4388_at YHR139C/SPS100, sporulation-specific wall maturation and cell-differentiation protein — 3.2
6113_at YDR371w/CTS2, sporulation-specific chitinase involved in cellular differentiation — 4.7
7409_at YBL043W/ECM13 involved in cell-wall synthesis — 2.5
10853_at YJR151C/DAN4 cell-wall mannoprotein, similar to YKL224c, Sta1p — 22.6
8526_at YOR009W/TIR1 cell-wall mannoprotein, involved in cell-wall maintanance — 24.0
8527_at YOR010C/TIR2 cold shock induced protein — 23.3
9628_at YMR006C/PLB2 lysophospholipase/phospholipase B — 23.6
DNA Related
5970_at YDR501w/PLM2, plasmid maintenance protein; mutant shows 2mu-m plasmid instability 8.6 7.3
4045_s_at YIL066C/RNR3, ribonucleotide reductase, large subunit expressed only after DNA damage 8.4 —
Amino Acid Metabolism
5196_at YGL184C/STR3, cystathionine beta-lyase 2.0 3.6
6915_at YCL064C/CHA1, L-serine/L-threonine deaminase 6.1 12.6
Isoprenoid Metabolism
8642_at YOL101C/IZH4 implicated in zinc homeostasis, membrane protein — 28.1
9854_at YLR450W/HMG2 3-hydroxy-3-methylglutaryl-coenzyme A reductase A — 22.6
Cell Cycle
8380_at YOR178c/GAC1 ser/thr phosphoprotein phosphatase, cell-cycle checkpoint — 22.5
Other
4194_at YIL117C/PRM5, pheromone-regulated protein, induced during cell-integrity signaling — 2.6
5372_at YFL014W/HSP12, heat-shock protein — 2.6
8338_at YOR226C/mitochondrial matrix protein required for synthesis of iron sulfur proteins — 3.0
8399_at YOR152C/protein of unknown function localized to ER — 2.9
8399_at YOR107W/RGS2, negative regulator of glucose induced cAMP signaling pathway — 2.7
9305_at YMR299C/DYN3, light intermediate chain of dynein — 3.8
9567_at YMR081C/ISF1 involved in suppression of mitochondrial splicing defect — 22.7cytochrome c peroxidase genes has been observed
with treatment of Rhodobacter sphaeroides with hy-
drogen peroxide [51]. The mechanism by which organ-
isms cope with damage inflicted by reactive oxygen
species varies from organism to organism, wherebynonessential genes are downregulated [51]. The involve-
ment of catalase and superoxide dismutase (SOD) have
both been detected in yeast exposed to pyocyanin at
0.5–1.5 hr posttreatment [38]. The absence of these
genes from the transcriptional profile (measured at
Chemistry & Biology
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life of the mRNA of these genes.
The production of hydrogen peroxide by pyocyanin
treatment was further exemplified by the upregulation
of genes associated with DNA damage. Although hydro-
gen peroxide (H2O2) itself does not inflict DNA damage,
it is readily converted to hydroxyl radicals by transition
metals such as iron (via the Fenton reaction) (Figure 4),
resulting in the production of DNA radicals [52, 53].
Pyocyanin itself has also been shown to bind double-
stranded DNA (with no base specificity) and inhibit
DNA template controlled RNA synthesis [76]. Two DNA
damage-response proteins, RNR3 and PLM2, were
upregulated with pyocyanin treatment. RNR3, the large
subunit of ribonucleotide reductase, was upregulated
by 8.4-fold. Ribonucleotide reductases catalyze the
reduction of nucleotide triphosphates to their corre-
sponding deoxynucleotide triphosphates, playing a cen-
tral role in DNA synthesis [54] and in response to DNA
damage [55, 56]. PLM2 is a plasmid-maintenance pro-
tein and was upregulated in its expression up to 8.6-
fold. Expression of this gene product is coupled with
DNA damage [57] and has been shown to activate genes
involved in DNA damage checkpoint and repair [58].
The damaging effects of hydroxyl radicals on DNA
notwithstanding [52, 53], lipoperoxidation can also
result, causing enhanced cell-wall permeability [51,
59–61]. Interestingly, a variety of cell-wall proteins
were differentially expressed with pyocyanin treatment.
While these effects have not been previously docu-
mented with pyocyanin exposure, they are consistent
with the ability of the compound to redox cycle and gen-
erate reactive oxygen species. For example, SPS100,
a protein that plays a protective role during the early
stages of spore-wall formation, was enhanced in its
expression by 3.2-fold [62]. CTS2, a sporulation-specific
chitinase expressed during spore-wall synthesis was
upregulated by 4.7-fold. Deletion of CTS2 has been
shown to decrease surface density of the spore [63].
ECM13, another protein involved in cell wall biosynthe-
sis, was increased in its expression by 2.5-fold, although
the exact function of this gene has yet to be established
Figure 4. Correlation of Gene Changes Generated from Yeast Tran-
scriptional Profile Data[64]. On the contrary, cell-wall mannoproteins, DAN4,
TIR1, and TIR2, were shown to be downregulated with
pyocyanin treatment (22.6-fold, 24.0-fold, and 23.3-
fold, respectively). Each of these genes is responsible
for the synthesis of cell-wall mannoproteins that are
necessary for anaerobic growth [65]. Similarly, PLB2
a phospholipase involved in lipid metabolism was also
downregulated. Presumably, these are nonessential
genes for the survival of the organism under these
oxidative conditions [66].
Collectively, the gene changes resulting from pyocya-
nin support the purported role of this compound as an
inducer of oxidative damage. Although the transcrip-
tional effects of the natural product have not been previ-
ously reported, we were intrigued to find that differen-
tially expressed transcripts roughly paralleled those
observed with hydrogen peroxide treatment [51,
67–71]. Pyocyanin has also been screened against
a yeast deletion library as a means to identify potential
protein targets [38]. Targets identified in this study
also supported the ability of this compound to redox
cycle and promote oxidative stress encompassing
proteins involved in the cell cycle, electron transport
and respiration, epidermal cell growth, protein sorting,
vesicle transport, and the vacuolar ATPase [38].
Confirmation of Selected Gene Changes by RT-PCR
Validation of the transcriptional effects induced by
pyocyanin treatment was demonstrated by semiquanti-
tative reverse transcriptase (RT)-PCR of an arbitrary
subset of the gene changes, including glutathione
peroxidase (YBR244W), catabolic serine (threonine)
dehydratase, iso-2-cytochrome c (YEL039C), and cysta-
thionine b-lyase (YGL184C). The procedure, while less
sensitive and quantitative than real-time PCR, is capable
of confirming a transcriptional response, the presence
or absence of a transcriptional effect. Normalization of
the RNA/cDNA was based upon glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) that was unaf-
fected by drug exposure. The results are provided as
Supplemental Data.
Significance
In summary, we probed the hypothesis that microbial
interactions in themarine environment can impact nat-
ural product production. Marinemicrobial populations
were cultured and examined for antibiotic activity.
Among the mixed cultures examined was a bacterium
that was found to act synergistically with select micro-
bial species to produce a blue compound. The bacte-
rium was identified as Pseudomonas aeruginosa,
and the blue metabolite as pyocyanin. Full structural
analysis of pyocyanin, including X-ray analysis and
2D-NMR, was carried out. Corrections were made to
1H-NMR and 13C-NMR assignments of the compound
that weremisreported in the chemical literature. Taken
together, the data gleaned from these investigations
suggest the importance of investigating not only or-
ganic extracts generated from single colonies, but
also those from mixed microbial populations for
bioactivity. The strategy could lead to the discovery
of otherwise unexpressed compounds. While the
procedures detailed here were for the microbial
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tated our analyses, the approach is broadly applicable
toward the investigation ofmetabolites of other organ-
isms. The primary procedural modification would
involve examination and comparison of extracts gen-
erated from microbial communities and pure cultures
by TLC and LC/MS.
Experimental Procedures
Instrumentation and General Methods
Unless otherwise specified, biochemical reagents were obtained
from Sigma Biochemicals (St. Louis, MO). Instant Ocean utilized in
marine medium preparations was obtained from Petco (College
Station, TX). All other medium reagents were obtained from VWR In-
ternational (West Chester, PA). Dichloromethane (CH2Cl2), chloro-
form (CHCl3), and methanol (MeOH) were purchased from EMD,
while ammonium hydroxide (NH4OH) was purchased from EM Sci-
ence (VWR International, West Chester, PA). All were used without
further purification. Flash column chromatography was performed
with grade 62 silica gel (EMD, 60–200 mesh). 1H-NMR spectra
were obtained with a Varian Inova-300 spectrometer (Palo Alto,
CA), in methanol-d4 (Aldrich; Milwaukee, WI).
1H-NMR (300 MHz)
spectra are reported as follows: chemical shifts in ppm downfield
from TMS, the internal standard (d-scale); multiplicity (s, singlet; d,
doublet; t, triplet; m, multiplet), integration, and coupling constant
(Hz). 13C- and other 2D NMR spectra were obtained on a Bruker
ARX500 spectrometer. 13C-NMR (125 MHz) spectra were recorded
in proton decoupled mode and reported in ppm. Preparative high-
performance liquid chromatography (HPLC) separations were con-
ducted on a Varian ProStar 230 solvent delivery module equipped
with a Varian ProStar 330 Photodiode Array Detector (Palo Alto,
CA) by using a Phenomenex Luna 5m Silica (2503 10.0 mm) column
(Torrance, CA). Infrared (IR) spectra were obtained on a Perkin-El-
mer FT-IR spectrometer (Boston, MA) with absorption peaks re-
ported in wave number (cm21). Mass spectra were recorded on
a PE Sciex with an API Qstar Pulsar (Concord, Ontario, Canada).
The Affymetrix platform (Santa Clara, CA) was used in all GeneChip
experiments. Cell-density measurements were made with a Biotek
mQuant plate reader.
Organisms
All marine microorganisms utilized in these experiments were
obtained from field collections. Hon6 (isolate 6) was acquired from
Honokohau, Maui, Pup16 (isolate 14) from Pupukea, Oahu, and
KM1 (isolate 1) from the Florida Keys. Pup14A and Pup14B were
also obtained from Pupukea (sample 14). The identity of each of
the microorganisms was assigned by the Centralbureau voor
Schimmelcultures (CBS) in the Netherlands. The yeast S. cerevisiae
wild-type strain (#404; BY4741; MATa his3[d]1 leu2[d]0 met15[d]0
ura3[d]0) was obtained from Dr. Michael Kladde at the Department
of Biochemistry, Texas A&M University. E. coli DH10B was obtained
from Invitrogen (Carlsbad, CA).
Field Collection of Marine Microbial Samples
Marine agar plates were prepared with slight modification to stan-
dard literature protocols [13]. Yeast extract (2 g), bactopeptone
(2 g), glucose (4 g), and bacto-agar (Difco, 20 g) were combined in
1 liter of seawater, prepared by mixing Instant Ocean (38 g, Petco)
with deionized distilled water. The marine agar plates were further
supplemented with either 10 mg/l of miconazole or a combination
of chloramphenicol (10 mg/l) and kanamycin (10 mg/l) for culturing
of bacteria or fungi, respectively. Culture swabs (Becton Dickinson,
supplier VWR International; West Chester, PA) were utilized to swab
submerged rocks, and autoclaved vials were used to collect ocean
floor sediments. Samples were applied to both types of marine agar
plates and incubated at room temperature for one week. Single
colonies were generated by repeated streaking of microorganisms
onto fresh plates. To generate marine microbial populations, cell
scrapers (Costar, supplier VWR International; West Chester, PA)
were applied to the original plates, and the cells resuspended and
cultured in marine broth.IC50 Determination
Overnight cultures (5 ml) of S. cerevisiae or E. coli were generated.
S. cerevisiae was cultured in YPD broth (30C, 250 rpm) [72] and
E. coli in LB medium [73]. Cultures were diluted to an OD600 0.1
and aliquoted (100 ml per well) into a 96-well plate. To each culture
was added 1 ml of serial dilutions of the crude extract (solubilized
in ethanol) or ethanol alone. All assays were executed in triplicate.
The 96-well plate was incubated at 30C, 250 rpm for 12 hr. Empty
wells were filled with 100 ml of autoclaved water to prevent evapora-
tion during incubation. Cell density was measured on a Biotek
mQuant plate reader (Winooski, Vermont).
Examination of Synergism
Split/Pool Analysis
Single colonies (60) were streaked and individually numbered on
marine agar plates. The cells were each individually resuspended
in marine broth and brought to an OD600 1.0. Initially, the cells
were each cultured ten at a time. To 5 ml aliquots of marine broth
was added 10 ml of each cell sample (in pools of ten, ten cell sam-
ples/5 ml marine broth). The samples were cultured for 3–4 days.
Several pools gave the green phenotype. We focused on one of
those pools and repeated the assay again but pooling two samples
at a time (two cell samples/5 ml marine broth). As a control, we also
cultured each sample individually, but no induction was observed in
this case.
Varying the Ratio of Pup14A to Pup14B
Pup14A and Pup14B were streaked onto marine agar plates and
grown to confluency. The cells were resuspended in marine broth
and brought to an OD600 1.0. The concentration of Pup14A (200 ml)
was held constant and mixed with different amounts of Pup14B (at
1, 10, 50, 100, and 200 ml) and vice versa in marine broth (5 ml).
The concentration of Pup14B (200 ml) was held constant and the
amount of Pup14A varied (at 1, 10, 50, 100, and 200 ml).
Inhibition Assays
Pup14A and Pup14B were cultured overnight at 30C, 250 rpm.
Cultures were diluted to an OD600 0.1 and aliquoted (100 ml per
well) into a 96-well plate. To each culture was added 1 ml of pyocya-
nin (solubilized in ethanol; stock solutions of 1, 10, and 100 mg/ml to
give final concentrations of 10 mg/ml, 100 mg/ml, and 1 mg/ml) or
ethanol alone. All assays were executed in triplicate. The 96-well
plate was incubated at 30C, 250 rpm for 12 hr. Empty wells were
filled with 100 ml of autoclaved water to prevent evaporation during
incubation. Cell density was measured on a Biotek mQuant plate
reader (Winooski, Vermont).
Small-Molecule Induction Assay
Pup14A and Pup14B were cultured on marine agar plates for two
days as described above. The agar plates were then sliced into
pieces. Agar from one half of each plate was added to separate 2 liter
Erlenmeyer flasks containing 1 liter of marine broth. Two sets of each
culture (corresponding to a total of four 2 liter flasks) were allowed to
grow at 30C at 250 rpm for 24 and 72 hr, respectively, and subse-
quently centrifuged. The media from each culture were filtered
through a 0.2 mm filter (Nalgene) and transferred to autoclaved flasks
(2 liter). Pup14A cells (24 and 72 hr) were added to the medium of
Pup14B (24 and 72 hr) and vice versa. Cultures were again placed
in a rotary shaker at 30C for 3 days. As a control, the other half of
each plate (Pup14A and Pup14B) was cocultured in 1 liter of marine
medium for 2–3 days until the coloration of the medium turned from
yellow to green.
Boyden Chamber Assay
The Boyden chamber assay was performed with Corning transwell
plates (0.4 mm pore diameter, 24 mm diameter, 6-well, Corning,
NY). Marine broth (1 ml) was added to the top and bottom chambers
of the wells of the plate and subsequently inoculated with the ap-
propriate microbial strains. The plates were incubated at 30C for
2 days without shaking. Following incubation, the cultures (from
the bottom chamber of the wells) were extracted with methylene
chloride and centrifuged to give two distinct layers, and the organics
were transferred to fresh tubes and concentrated tow100 ml volume
for comparison.
Induction of Blue Phenotype with Different Strains
Microorganisms Pup14A and Pup14B, Hon6, Pup16, Surf 1, and
KM1 were cultured on marine agar plates to confluency and resus-
pended in marine medium to give an OD600 1.0. Pup14A or
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200 ml of Hon6, Pup16, or KM1. As a control, Pup14A and Pup14B
(200 ml each) were mixed and cultured. All cultures were grown at
30C, 250 rpm for a period of a week.
Samples were evaporated to dryness, redissolved in dichlorome-
thane, and examined by HPLC. An isocratic solvent system of 87:13
CH2Cl2/5% NH4OH in MeOH was employed. Under these conditions,
pyocyanin elutes with a retention time (Rt) of 7.23 min. Pyocyanin
gives a characteristic blue phenotype and is easily detected upon
collection. Purified pyocyanin was collected, concentrated in vacuo
and its identity confirmed by mass spectrometry.
Isolation and Characterization of Pyocyanin
Purification Conditions
Liquid cultures (2 l) were extracted twice with 1 l of dichloromethane.
Fractions were combined, and the solvent evaporated under vac-
uum. The organic residue was partially purified by flash-column
chromatography with silica gel as the stationary phase and
10:1:0.001 CH2Cl2/MeOH/NH4OH as the mobile phase. Fractions
were analyzed by TLC utilizing the same conditions. Fractions
containing the blue compound were combined and the solvent
evaporated to dryness. The remaining semipure residue was
dissolved in 1 ml dichloromethane and precipitated with 2 ml hex-
anes. After standing on ice for 5 min, the sample was centrifuged
at 14,000 rpm at 4C for 1 min to pellet the blue material and the
solvent aspirated off. The precipitation procedure was repeated
five times.
HPLC Conditions
Further purification of pyocyanin was performed via high perfor-
mance liquid chromatography (HPLC). The blue organic residue
was dissolved in dichloromethane and purified by HPLC utilizing
an isocratic solvent system (87:13 CH2Cl2/5% NH4OH in MeOH).
The purified pyocyanin was collected with a retention time (Rt) of
8.63 min, concentrated in vacuo, and stored at 280C. Approxi-
mately 2 mg of pyocyanin can be generated per liter of cells.
Crystallization Conditions
Pyocyanin (1 mg) was dissolved in 0.5 ml 1:1 CH2Cl2:CHCl3 and
placed into a test tube equipped with a female ground glass joint.
The joint was connected to a Dean-Stark trap which contained
6 ml hexanes in the collection tube. The test tube was submerged
in an ice bath. The remainder of the apparatus was maintained at
room temperature. Green-blue crystals formed within 48 hr.
Characterization Data
1H-NMR (300 MHz, methanol-d4) 8.38 (d, J = 8.4 Hz, 1H), 8.12 (m, 2H),
7.99 (t, J = 8.4Hz, 1H), 7.79 (t, J = 7.0 Hz, 1H), 6.67 (dd, J = 8.4, 4.1 Hz,
2H), 3.95 (s, 3H); 13C NMR (75 MHz, Methanol-d4) 177.5, 147.3, 146.7,
138.5, 138.1, 136.4, 134.4, 134.0, 128.0, 116.8, 115.5, 95.3, 36.7; IR
(neat solid) 2982, 1599, 1454 cm21; HRMS (ESI) for C13H11N2O
(M+H)+: calcd 211.0871, found 211.0885.
Spectral data are published as Supplemental Data. X-ray data are
available through the Cambridge Crystallographic Data Centre
(deposition number: CCDC 626277).
Detection of Phenazine Biosynthetic Loci- and Quorum-
Sensing Regions
P. aeruginosa strain Pup14B was cultured as detailed above and
genomic DNA isolated from 125 mg of the cell pellet. The pellet
was washed twice with 1.5 ml of TE buffer (10 mM Tris, 1 mM
EDTA [pH 7.5]) and resuspended in 2 ml of TE buffer. To this
was added 2 ml of lysis buffer (0.5 M EDTA, 1% w/v SDS [pH
9.0]) and 1 mg of proteinase K (Sigma-Aldrich). The sample was
incubated at 50C for 16 hr. The solution volume was doubled
with water, extracted with chloroform, and the DNA isolated by
spooling [73]. The DNA was resuspended in 500 ml of TE and
treated with 10 ml of 1 mg/ml RNase A for 2 hr at 37C. This solu-
tion was extracted with an equal volume of chloroform, the DNA
precipitated with isopropanol, and the pellet washed with 70%
ethanol. The DNA pellet was dried and respended in 250 ul of
TE buffer.
The 700 bp sequence upstream of the phzA1 gene was amplified
by PCR from the Pup14B genomic DNA with the pyo las F and pyo
las R primer set. The reaction contained (in 50 ml) 13 ThermoPol
Reaction Buffer, 2.5% DMSO, 250 mM of dNTP’s, 2 U Taq DNA
polymerase (New England Biolabs, Ipswich, MA), 50 pmol of eachprimer, and 20 ng of genomic DNA template. Thermal cycling was
performed with a PTC-200 thermal cycler (MJ Research, Waltham,
MA) by using an initial 2 min denaturing step at 94C, followed by
30 cycles of 94C for 30 s, 30 s at the annealing temperature of
55C, and 1 min at 68C. After cycling, the reaction was held at
68C for 7 min. Similarly, the 2041 bp region upstream of the
phzA2 gene was amplified in overlapping sections from genomic
DNA by using three primer sets, phz2_las forward and reverse
(480 bp), phz2_up2 forward and reverse (1102 bp), and phz2_up3
forward and reverse (937 bp). The same reaction conditions and
temperature cycles were used, except that the annealing tempera-
ture was 59C for the phz2_las primer pair and 50C for the phz2_up2
and phz2_up3 primer pairs. The PCR products were gel purified and
TOPO-TA cloned (Invitrogen, Carlsbad, CA).
PCR Primers
pyo las, 55C: forward, 50-GTAACCCGAGAAGTACCCAAGCG-30;
reverse, 50-TTTCCCTGTACCGCTGACCGTTC-30. phz2 las, 59C:
forward, 50-ACGCCATCGGCCTGCTCAACTG-30; reverse, 50-GGTAA
ACCCTTTCAACCGTTGG-30. phz2_up2, 50C: forward, 50-CTCTTCA
GCCTCGTTTCGTC-30; reverse, 50-CCCGGAAAGTTGCACTAGC-30.
phz2_up3, 50C: forward, 50-GGAACCAACTGTTCCAGCAT-30; re-
verse, 50-CCTGGGTAATTGGACAGGAA-30.
Cloned fragments were end sequenced with primers PCR2.1seq
forward and reverse. Gaps were filled by chromosome walking
with the primers 3-4 left, 3-4 right, 2-3 left, and 2-3 right. Sequencing
reactions were performed with the Perkin Elmer ABI BigDye Termi-
nator kit according to the manufacturer’s instructions and analyzed
on an ABI 31303/Genetic Analyzer by the Gene Technology Lab
Core Facility of Texas A&M University. Primer design for these
procedures was aided by Primer 3 software (source code available
at http://fokker.wi.mit.edu/primer3/) [75].
Sequencing Primers
PCR2.1seq: forward, 50-CAGGAAACAGCTATGACCATG-30; reverse,
50-AGATGCATGCTCGAGCGGCCGCC-30.
Chromosome Walking Primers
3-4 Left: 50-CTTTTTAATTGCCTCAGAAT-30. 2-3 Left: 50-AGATATG
CGGTAATTATGGA-30. 3-4 Right: 50-AACCGTAGAACGGCTCTC-30.
2-3 Right: 50-GTGATCCAGAGCAGGAAG-30. Sequence data are
published as Supplemental Data.
Yeast Sample Preparation and GeneChip Evaluation
Yeast was cultured overnight in YPD broth [72] to an OD600 of 1.0.
Total RNA was extracted with an SDS/hot phenol extraction method
[72] and treated with DNase as follows. Total RNA (30 ml) was incu-
bated at room temperature with 5 ml of first strand buffer (GIBCO-
BRL cDNA Superscript Choice Kit; Carlsbad, CA) and 1 ml of DNase
I (RNase-free, Ambion). Samples were heat inactivated by heating
the samples at 75C for 15 min and subsequently purified with an
RNeasy kit (QIAGEN, Valencia, CA). The samples (15 mg of total
RNA per sample) were provided to the GeneChip facility where
they were amplified, biotinylated, and hybridized to GeneChips
according to the protocol detailed by Affymetrix (Santa Clara, CA).
Microarray data are available through the NCBI Geo Database
(accession number: GSE6185).
RT-PCR, Validation of GeneChip Results
RT-PCR was used to quantify the mRNA levels of the following:
glutathione peroxidase, catabolic serine (threonine) dehydratase,
iso-2-cytochrome c, and cystathionine b-lyase. Total RNA was
extracted from control cells and cells treated with pyocyanin
(25 mg/ml and 250 mg/ml). Following extraction, total RNA (10 mg)
was transcribed into single-stranded cDNA with the Superscript
Choice system (GIBCO-BRL). PCR reactions were conducted with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an en-
dogenous amplification standard. PCR conditions were optimized
so that amplification of both GAPDH and the cDNA of interest
were in the exponential phase (estimated by varying the number
of PCR cycles for each template or gene of interest). PCR cycles
consisted of: step 1, 5 min denaturation at 95C; step 2, 1 min of de-
naturation at 95C; step 3, 1 min of primer annealing at the appropri-
ate temperature (specified below); step 4, 1 min of extension at 72C.
Steps 2 through 4 were repeated for the requisite number of cycles.
PCR products were stained with Sybr Green and fluorescence was
measured with a microplate reader.
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Glutathione peroxidase, YBR244W, 44C: forward, 50-ATGACCACA
TCTTTTTATGATTTAG-30; reverse, 50-TCATTTACTTAACAGGCTTTG
GATT-30. Catabolic serine (threonine) dehydratase, YCL064C 45C:
forward, 50-CATCTTTGTCCTCTATTACAACGGA-30; reverse, 50-GGT
AGATAAAATCAGGAACACCGGT-30. Iso-2-cytochrome c, YEL039C,
45C: forward, 50-CTATTTGGCAGCCTTTGTCATATAA-30; reverse,
50-ATGGCTAAAGAAAGTACGGGATTCA-30. Cystathionine beta-
lyase, YGL184C, 45C: forward, 50-ATTGTGTTCTTCTAGAGTCT-30;
reverse, 50-TATTGAACGATTTATGCAGC-30. GAPDH, YJR009C,
55C: forward, 50-ACATTGACATCGCCATTGACTCCAC-30; reverse,
50-TTTCATCGTAGGTGGTTTCCTTGTT-30.
Supplemental Data
Supplemental Data include characterization data on pyocyanin,
sequence data demonstrating the presence of the phenazine
biosynthetic gene cluster and quorum-sensing region in Pup14B,
and RT-PCR analysis on select green changes observed by
transcriptional-array profiling. They are available at http://www.
structure.org/cgi/content/full/13/12/1349/DC1/.
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